Evidence map›Paper›PMID 36387024›Full record

ArticleiScience2022

YihE is a novel binding partner of Rho and regulates Rho-dependent transcription termination in the Cpx stress response.

Biying Wang, Hairun Pei, Zhifang Lu, Yingying Xu, Shengnan Han, Zongchao Jia, Jimin Zheng

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Biying WangCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Hairun PeiCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Zhifang LuCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Yingying XuCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Shengnan HanCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Zongchao JiaDepartment of Biomedical and Molecular Sciences, Queen's University, Ontario K7L 3N6, Canada.
Jimin ZhengCollege of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
Beijing Normal University · CNBeijing Technology and Business University · CNChinese Academy of Sciences · CNQueen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The conjugative pilus expression (Cpx) stress response system can sense cell envelope stressors, such as misfolded proteins, and upregulate proteases to modify or degrade damaged proteins. YihE is a protein kinase implicated in the Cpx system, and Rho is a transcription termination factor in prokaryotes, but no functional connection between YihE and Rho has been reported. Here, we found that YihE can interact with Rho to form a binary complex with a stoichiometric ratio of 6:1 (Rho:YihE). A low resolution of Rho crystal structure in the presence of YihE was determined. YihE overexpression helped lessen the aberrant effects caused by Rho overexpression, including long cell morphology and other Rho-mediated phenotypes. Overall, YihE is a Rho binding partner that acts as a Rho antagonist in the Cpx stress. YihE binding to Rho would compete RNA from binding to Rho, thereby helping bacteria cope with stress through the regulation of Rho-dependent transcription termination.

Indexed as

Biological sciencesmolecular biologyprotein structure aspectsstructural biology

Identifiers

PMID36387024
PMCPMC9663540
OpenAlexW4308156625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.